Skip to main content
;

INDU Committee Report

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

PDF

APPENDIX A: LETTER FROM SANOFI GENZYME

Health Canada does not prioritize innovation

Innovation Mandate FDA Logo

… FDA is also responsible for advancing the public health by helping to speed innovations that make medicines more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medicines and foods to maintain and improve their health. …

http://www.fda.gov/AboutFDA/WhatWeDo/default.htm

European Medicines Agency: Science Medicines Health

… Facilitate development and access to medicines

EMA is committed to enabling timely patient access to new medicines, and plays a vital role in supporting medicine development for the benefit of patients.

The Agency uses a wide range of regulatory mechanisms to achieve these aims, which are continuously reviewed and improved. …

http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/ general/general_content_000091.jsp

Protection Mandate Health Canada

The Health Products and Food Branch (HPFB)'s mandate is to take an integrated approach to managing the health-related risks and benefits of health products and food by:

  • minimizing health risk factors to Canadians while maximizing the safety provided by the regulatory system for health products and food; and,
  • promoting conditions that enable Canadians to make healthy choices and providing information so that they can make informed decisions about their health.

http://www.hc-sc.gc.ca/ahc-asc/branch-dirgen/hpfb-dgpsa/index-eng.php

Reproduced with the permission of Innovative Medicines Canada